Assignee
BEIJING INNOCARE PHARMA TECH CO LTD
CN·14 granted patents·11 pending applications·7 citations·filing 2014–2025
Top patents by PatentIndex Score
25 records- 0192US11572353B2Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Granted Feb 7, 2023·2 cites·17 claims
- 0285US9951056B2Substituted nicotinamide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune diseaseBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2014·Granted Apr 24, 2018·5 cites·4 claims
- 0371US10710981B2Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted Jul 14, 2020·0 cites·20 claims
- 0469US11059805B2Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2020·Granted Jul 13, 2021·0 cites·6 claims
- 0568US2025332105A1Amorphous solid dispersion comprising (s)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1h-pyrazole-4-carboxamideBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 0667US2023192691A1Heterocyclic compounds as btk inhibitorsBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 0767US2023212175A1Bridged bicyclic compounds as btk inhibitorsBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 0866US11578058B2Heterocyclic compounds for inhibiting TYK2 activitiesBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2022·Granted Feb 14, 2023·0 cites·8 claims
- 0963US12297188B2Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamideBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2022·Granted May 13, 2025·0 cites·6 claims
- 1061US2024307354A1Method for treating head and neck cancerBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 1160US2023348417A1Process for preparing (s)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl) ethynyl)-5-(methylamino)-1h-pyrazole-4-carboxamideBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 1258US12391666B2Indoline-1-formamide compound, preparation method therefor, and medical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·6 claims
- 1358US12202813B2Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamideBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Granted Jan 21, 2025·0 cites·5 claims
- 1458US12178808B2Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamideBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Granted Dec 31, 2024·0 cites·6 claims
- 1557US11945792B2Crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamideBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Granted Apr 2, 2024·0 cites·7 claims
- 1655US11389445B2Pentafluorosulfanyl-substituted amide derivatives, preparation methods thereof and medical uses thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted Jul 19, 2022·0 cites·5 claims
- 1754US2024246984A1Heterocyclic jak inhibitorBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 1854US2023271959A1Heterocyclic compound as bcl-2 inhibitorBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 1952US2023219946A1Pyrimidin-4(3h)-one heterocyclic compound, preparation method thereof, and pharmaceutical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 2051US2025262198A1Method for treating multiple sclerosisBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 2151US2023271933A1Heterocyclic immunomodulatorBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 2247US11878987B2Heterocyclic compound as TRK inhibitorBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted Jan 23, 2024·0 cites·10 claims
- 2342US2021221808A13-oxazolinone compound, preparation method therefor and pharmaceutical application thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Application pending·0 cites
- 2441US11046682B2Fused heterocyclic derivatives, their preparation methods thereof and medical uses thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2017·Granted Jun 29, 2021·0 cites·7 claims
- 2536US10336755B2Fused pyrazole derivatives, preparation method thereof, and use thereof in treatment of cancers, inflammation and immune diseasesBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2016·Granted Jul 2, 2019·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when BEIJING INNOCARE PHARMA TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →